Role of mitochondrial permeability transition in fetal brain damage in rats

Pediatric Neurology

Volumn 30, Issue 4, 2004, Pages 247-253

  Nakai, Akihito ^a   Shibazaki, Yukino ^b   Taniuchi, Yoshinari ^a   Miyake, Hidehiko ^a   Oya, Atsuko ^a   Takeshita, Toshiyuki ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENERGY; BRAIN CIRCULATION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN MITOCHONDRION; CELL ENERGY; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FETUS; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION SWELLING; NONHUMAN; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; BRAIN DAMAGE, CHRONIC; BRAIN ISCHEMIA; CEREBRAL CORTEX; CYCLOSPORINE; ENERGY METABOLISM; FEMALE; FETAL HYPOXIA; ION CHANNELS; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIAL SWELLING; PREGNANCY; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 1842861784     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2003.09.006     Document Type: Article

References (61)

1. Bernardi P., Basso E., Colonna R., et al. Perspectives on the mitochondrial permeability transition. Biochim Biophys Acta. 1365:1998;200-206.
2. Rehncrona S., Mela L., Siesjö B.K. Recovery of brain mitochondrial function in the rat after complete and incomplete cerebral ischemia. Stroke. 10:1979;437-446.
3. Hillered L., Siesjö B.K., Arfors K. Mitochondrial response to transient forebrain ischemia and recirculation in rat. J Cereb Blood Flow Metab. 4:1984;438-446.
4. Allen K., Almeida A., Bates T., Clark J. Changes of respiratory chain activity in mitochondrial and synaptosomal fractions isolated from the gerbil brain after graded ischaemia. J Neurochem. 64:1995;2222-2229.
5. Almeida A., Allen K.L., Bates T.E., Clark J.B. Effect of reperfusion following cerebral ischaemia on the activity of the mitochondrial respiratory chain in the gerbil brain. J Neurochem. 65:1995;1698-1703.
6. Kuroda S., Katsura K., Hillered L., Bates T.E., Siesjö B.K. Delayed treatment with α-phenyl-N-tert-butyl-nitrone (PBN) atttenuates secondary mitochondrial dysfunction after transient focal ischemia in the rat. Neurobiol Dis. 3:1996;149-157.
7. Nakai A., Kuroda S., Kristian T., Siesjö B.K. The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction folowing transient focal cerebral ischemia in the rat. Neurobiol Dis. 4:1997;288-300.
8. Sims N.R., Pulsinelli W.A. Altered mitochondrial respiration in selectively vulnerable brain subregion following transient forebrain ischemia in the rat. J Neurochem. 49:1987;1367-1374.
9. Kuroda S., Siesjö B.K. Reperfusion damage following focal ischemia Pathophsiology and therapeutic windows. Clin Neurosci. 4:1997;199-212.
10. 2+ dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J. 255:1988;357-360.
11. Duchen M.R., McGuinness O., Brown L.A., Crompton M. On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc Res. 10:1993;1790-1794.
12. 2+ Their relationship to apoptosis and oncogenesis. FEBS. 325:1993;104-107.
13. Bernardi P., Broekemeier K.M., Pfeiffer D.R. Recent progress on regulation of the mitochondrial permeability transition pore A cyclosporin-sensitive pore in the inner mitochondrial membrane. J Bioenerg Biomemb. 26:1994;509-517.
14. Gunter K.K., Gunter T.E. Transport of calcium by mitochondria. J Bioenerg Biomemb. 26:1994;471-485.
15. Zamzami N., Susin S.A. Mitochondrial control of nuclear apoptosis. J Exp Med. 183:1996;1533-1544.
16. Hirsch T., Marzo I., Kroemer G. Role of the mitochondrial permeability transition pore in apoptosis. Biosci Rep. 17:1997;67-76.
17. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 28:1998;1309-1312.
18. Friberg H., Connern C., Halestrap A.P., Wieloch T. Differences in the activation of the mitochondrial permeability transition among brain regions in the rat correlate with selective vulnerability. J Neurochem. 72:1999;2488-2497.
19. Crompton M., Andreeva L. On the involvement of a mitochondrial pore in reperfusion injury. Basic Res Cardiol. 88:1993;513-523.
20. Broekemeier K.M., Dempsey M.E., Pfeiffer D.R. Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J Biol Chem. 264:1989;7826-7830.
21. 2+-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem J. 268:1990;153-160.
22. Connern C.P., Halestrap A.P. Purification and N-terminal sequencing of peptidyl-prolyl cis-trans-isomerase from rat liver mitochondrial matrix reveals the existence of a distinct mitochondrial cyclophilin. Biochem J. 284:1992;381-385.
23. 2+ and oxidant stress. Eur J Biochem. 238:1996;469-471.
24. Uchino H., Elmer E., Uchino K., Siesjö B.K. Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischaemia in the rat. Acta Physiol Scand. 155:1995;469-471.
25. Butcher S.P., Henshall D.C., Teramura Y., Iwasaki K., Sharkey J. Neuroprotective actions of FK506 in experimental stroke In vivo evidence against an antiexcitotoxic mechanism. J Neurosci. 15:1997;6939-6946.
26. Yoshimoto T., Siesjö B.K. Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia. Brain Res. 839:1999;283-291.
27. Nakai A., Asakura H., Taniuchi Y., Koshino T., Araki T., Siesjö B.K. Effect of α-phenyl-N-tert-butyl nitrone (PBN) on fetal cerebral energy metabolism during intrauterine ischemia and reperfusion in rats. Pediatr Res. 47:2000;451-456.
28. Nakai A., Taniuchi Y., Asakura H., Yokota A., Koshino T., Araki T. Secondary mitochondrial dysfunction after transient intrauterine ischemia in the fetal brain. J Obstet Gynecol Res. 26:2000;383-387.
29. Nakai A., Shibazaki Y., Taniuchi Y., Koshino T., Yokoyama K. Maternal treatment with NMDA receptor antagonist (MK-801) attenuates secondary mitochondrial dysfunction after transient intrauterine ischemia in neonatal rat brain. J Anesthesia. 15:2001;217-222.
30. Azzopardi D., Wyatt J.S., Cady E.B., et al. Prognosis of newborn infants with hypoxic-ischemic brain injury assessed by phosphorus magnetic resonance spectroscopy. Pediatr Res. 25:1989;445-451.
31. Nioka S., Smith A., Mayevsky A., et al. Age dependence of steady state mitochondrial oxidative metabolism in the in vivo hypoxic dog brain. Neurol Res. 13:1991;25-32.
32. Yager J.Y., Brucklacher R.M., Vannucci R.C. Cerebral energy metabolism during hypoxia-ischemia and early recovery in immature rats. Am J Physiol. 262:1992;H672-677.
33. Lorek A., Takei Y., Cady E.B., et al. Delayed (secondary) cerebral energy failure after acute hypoxia-ischemia in newborn piglet Continuous 48-hour studies by phosphorus magnetic resonance spectroscopy. Pediatr Res. 36:1994;699-706.
34. Gilland E., Puka-Sundvall M., Hillered L., Hagberg H. Mitochondrial function and energy metabolism after hypoxia-ischemia in the immature rat brain Involvement of NMDA-receptor. J Cereb Blood Flow Metab. 18:1998;297-304.
35. Roth S.C., Edwards A.D., Cady E.B., et al. Relation between cerebral oxidative metabolism following birth asphyxia, and neurodevelopmental outcome and brain growth at one year. Dev Med Child Neurol. 34:1992;285-295.
36. Tanaka M., Natori M., Ishimoto H., Miyazaki T., Kobayashi T., Nozawa S. Experimental growth retardation produced by transient period of uteroplacental ischemia in pregnant Sprague-Dawley rats. Am J Obstet Gynecol. 171:1994;1231-1234.
37. Nakai A., Shibazaki Y., Taniuchi Y., et al. Influence of mild hypothermia on delayed mitochondrial dysfunction after transient intrauterine ischemia in the immature rat brain. Brain Res Dev Brain Res. 128:2001;1-7.
38. Folbergrova J., MacMillan V., Siesjö B.K. The effect of moderate and marked hypercapnia upon the energy state and upon the cytoplasmic NADH/NAD+ ratio of the rat brain. J Neurochem. 19:1972;2497-2505.
39. Lowry O., Rosebrough N., Farr A., Randall R. Protein measurement with folin phenol reagent. J Biol Chem. 193:1951;265-275.
40. Rosenthal R.E., Hamud F., Fiskum G., Varghese P.J., Sharpe S. Cerebral ischemia and reperfusion of brain mitochondrial injury by lidoflazine. J Cereb Blood Flow Metab. 7:1987;752-758.
41. Sims N., Blass J. Expression of classical mitochondrial respiratory responses in homogenates of rat forebrain. J Neurochem. 47:1986;496-505.
42. Nakai A., Taniuchi Y., Asakura H., et al. Developmental changes in mitochondrial activity and energy metabolism in fetal and neonatal rat brain. Brain Res Dev Brain Res. 121:2000;67-72.
43. Nakai A., Taniuchi Y., Asakura H., et al. Developmental changes in tolerance to transient intrauterine ischemia in rat cerebral mitochondria. Am J Obstet Gynecol. 184:2001;731-735.
44. Chance B., Williams G. A method for the localization of sites for oxidative phosphorylation. Nature. 178:1955;250-254.
45. Kristian T., Gertsch J., Bates T.E., Siesjö B.K. Characteristics of the calcium-triggered mitochondrial permeability transition in nonsynaptic brain mitochondria Effect of cyclosporin A and ubiquinone 0. J Neurochem. 74:2000;1999-2009.
46. Kobayashi T. The role of mitochondrial permeability transition in brain ischemia. Hokkaido J Med Sci. 75:2000;243-252.
47. Auer R., Kalimo H., Olsson Y., Wieloch T. The dentate gyrus in hypoglycemia Pathology implicating excitotoxin-mediated neuronal necrosis. Acta Neuropathol. 67:1985;279-288.
48. Friberg H., Ferrand-Drake M., Bengtsson F., Halestrap A.P., Wieloch T. Cyclosporin A, but not FK506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J Neurosci. 18:1998;5151-5159.
49. Folbergrova J., Zhao Q., Katsura K., Siesjö B.K. N-tert-α-phenylnitrone improves recovery of brain energy state in rats following transient focal ischemia. Proc Natl Acad Sci USA. 92:1995;5057-5061.
50. Siesjö B.K., Elmer E., Janelidze S., et al. Role and mechanisms of secondary mitochondrial failure. Acta Neurochir. 72:(Suppl.):1999;7-13.
51. Shibazaki Y., Nakai A., Koshino T., Yokoyama K. Effect of the immunosuppressant drug FK506 on neonatal cerebral mitochondrial function and energy metabolism after transient intrauterine ischemia in rats. Brain Res. 892:2001;351-358.
52. Ouyang Y.-B., Kuroda S., Kristian T., Siesjö B.K. Release of mitochondrial aspartate aminotransferase (mAST) following transient focal ischemia suggests the opening of a mitochondrial permeability transition pore. Neurosci Res Comm. 20:1997;167-173.
53. Asakura H., Nakai A., Yokota A., Sekiguchi A., Koshino T., Araki T. Continuous observation of nitric oxide production in the fetal rat brain during uteroplacental ischemia. Fetal Diagn Ther. 14:1999;354-359.
54. Packer M.A., Murphy M.P. Peroxynitrite formed by simultaneous nitric oxide and superoxide generation causes cyclosporin-A-sensitive mitochondrial calcium efflux and depolarisation. Eur J Biochem. 234:1995;231-239.
55. Liu X., Kim C.N., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell free extracts Requirement for dATP and cytochrome C. Cell. 86:1996;147-157.
56. Wyllie A.H., Kerr J.F.R., Currie A.R. Cell death The significance of apoptosis. Int Rev Cytol. 68:1980;251-306.
57. Kerr J.F.R., Gobe G.C., Winterford C.M., Harmin B.V. Anatomical methods in cell death. Meth Cell Biol. 46:1995;1-27.
58. Gogvadze V. Cyclosporin A protects mitochondria in an in vitro model of hypoxia/reperfusion injury. FEBS Lett. 333:1993;334-338.
59. Begley D.J., Squires L.K., Zlokovic B.V., et al. Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A. J Neurochem. 55:1990;1222-1230.
60. Shirai A., Naito M., Tatsuta T., et al. Transport of cyclosporin A across the brain capillary endothelial cell monolayer by P-glycoprotein. Biochim Biophys Acta. 1222:1994;400-404.
61. Bernareggi A., Rowland M. Physiologic modeling of cyclosporin kinetics in rat and man. J Pharmacokinet Biopharm. 19:1991;21-50.